Breaking News Instant updates and real-time market news.

SUPN

Supernus

$44.25

0.2 (0.45%)

05:54
07/17/17
07/17
05:54
07/17/17
05:54

Supernus downgraded to Neutral from Overweight at Piper Jaffray

Piper Jaffray analyst David Amsellem downgraded Supernus Pharmaceuticals to Neutral and raised his price target for the shares to $46 from $44. The analyst sees "muted" prospects for "significant value creation" in the second half of 2017 due to valuation and the wider spread between gross and net sales amid Trokendi promotions.

  • 19

    Jul

SUPN Supernus
$44.25

0.2 (0.45%)

03/24/17
RHCO
03/24/17
NO CHANGE
RHCO
Supernus price target raised to $45 from $37 at SunTrust
SunTrust analyst John Boris raised his price target on Supernus as he increased his out-year estimates for the company's mirgraine treatment, Trokendi, and its bipolar treatment, Oxtellar. He expects the company's 2017 results to beat expectations by a significant amount ,and he keeps a Buy rating on the shares.
05/31/17
JEFF
05/31/17
NO CHANGE
Target $45
JEFF
Buy
Supernus price target raised to $45 from $35 at Jefferies
Jefferies analyst David Steinberg raised his price target for Supernus Pharmaceuticals to $45 citing "robust" early Trokendi in migraine prescription trends. The analyst increased his FY17-FY20 Trokendi estimates by $12M, $45M, $67M, and $80M, which he believes could prove conservative. Steinberg views the early launch of the drug as "impressive" and keeps a Buy rating on the shares.
06/01/17
PIPR
06/01/17
UPGRADE
Target $44
PIPR
Overweight
Supernus upgraded to Overweight from Neutral at Piper Jaffray
Piper Jaffray analyst David Amsellem upgraded Supernus Pharmaceuticals to Overweight and raised his price target for the shares to $44 from $30. The analyst's survey of 28 psychiatrists indicates the company's Oxtellar XR could gain "significant" traction in bipolar disorder. Further, the analyst believes label expansion could "easily double" Oxtellar XR's sales potential.
06/28/17
JEFF
06/28/17
NO CHANGE
Target $51
JEFF
Buy
Supernus price target raised to $51 after physician survey at Jefferies
Jefferies analyst David Steinberg raised his price target for Supernus Pharmaceuticals to $51 from $45 after conducting a survey of high prescribing physicians to gauge their views on Trokendi XR post the recent launch in migraine prophylaxis. The surveyed clinicians anticipate treating 26.6% of their severe migraine patients with Trokendi within five years post launch, Steinberg tells investors in a research note. This suggests theoretical Trokendi migraine revenue of $960M, or roughly two times the current consensus, the analyst points out. He keeps a Buy rating on Supernus.

TODAY'S FREE FLY STORIES

GHL

Greenhill & Co.

$17.10

0.05 (0.29%)

16:32
10/18/17
10/18
16:32
10/18/17
16:32
Hot Stocks
Greenhill & Co. 'substantially' reduces dividend to 5c per share »

"In order to improve…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Oct

KALU

Kaiser Aluminum

$104.26

0.84 (0.81%)

16:32
10/18/17
10/18
16:32
10/18/17
16:32
Earnings
Kaiser Aluminum reports Q3 adjusted EPS 90c, consensus $1.08 »

Reports Q3 revenue $333M,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Oct

UAL

United Continental

$67.99

0.48 (0.71%)

16:32
10/18/17
10/18
16:32
10/18/17
16:32
Hot Stocks
Breaking Hot Stocks news story on United Continental »

United Continental sees…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Oct

UAL

United Continental

$67.99

0.48 (0.71%)

16:31
10/18/17
10/18
16:31
10/18/17
16:31
Hot Stocks
Breaking Hot Stocks news story on United Continental »

United Continental sees…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Oct

CCI

Crown Castle

$100.96

-0.42 (-0.41%)

16:30
10/18/17
10/18
16:30
10/18/17
16:30
Earnings
Crown Castle sees FY18 AFFO $2.22B-$2.26B »

Sees FY18 site rental…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

16:30
10/18/17
10/18
16:30
10/18/17
16:30
Options
Preliminary option volume of 16.8M today »

Preliminary option volume…

RXDX

Ignyta

$16.25

1.9 (13.24%)

16:29
10/18/17
10/18
16:29
10/18/17
16:29
Syndicate
Ignyta announces $125M common stock offering »

Ignyta anticipates using…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Oct

  • 18

    Oct

  • 06

    Nov

CCI

Crown Castle

$100.96

-0.42 (-0.41%)

16:28
10/18/17
10/18
16:28
10/18/17
16:28
Earnings
Crown Castle sees Q4 AFFO $430M-$435M »

Sees Q4 site rental…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

PEGI

Pattern Energy

16:28
10/18/17
10/18
16:28
10/18/17
16:28
Syndicate
Pattern Energy files to sell 8M shares of Class A common stock »

The offering is being…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

USAP

Universal Stainless & Alloy

$21.12

-0.33 (-1.54%)

16:27
10/18/17
10/18
16:27
10/18/17
16:27
Hot Stocks
Breaking Hot Stocks news story on Universal Stainless & Alloy »

Universal Stainless &…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

BDN

Brandywine Realty

$17.93

-0.02 (-0.11%)

16:26
10/18/17
10/18
16:26
10/18/17
16:26
Hot Stocks
Brandywine Realty announces joint venture disposition »

"In addition to the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Oct

  • 14

    Dec

RXDX

Ignyta

$16.25

1.9 (13.24%)

16:25
10/18/17
10/18
16:25
10/18/17
16:25
Syndicate
Breaking Syndicate news story on Ignyta »

Ignyta files automatic…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Oct

  • 18

    Oct

  • 06

    Nov

NTB

Butterfield

$35.81

0.29 (0.82%)

16:25
10/18/17
10/18
16:25
10/18/17
16:25
Hot Stocks
Butterfield chief risk officer Frumkin named COO »

The Bank of N.T.…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Oct

  • 15

    Nov

VSEC

VSE Corp.

$58.21

0.01 (0.02%)

16:25
10/18/17
10/18
16:25
10/18/17
16:25
Hot Stocks
VSE Corp. awarded $35.6M in new delivery order awards »

VSE Corporation was…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ADBE

Adobe

$153.00

2.62 (1.74%)

16:25
10/18/17
10/18
16:25
10/18/17
16:25
Conference/Events
Adobe to hold a briefing »

Financial Analyst and…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Oct

  • 22

    Oct

  • 06

    Nov

HXL

Hexcel

$58.94

0.39 (0.67%)

16:24
10/18/17
10/18
16:24
10/18/17
16:24
Earnings
Hexcel narrows FY17 EPS guidance to $2.64-$2.72 from $2.64-$2.76 »

Consensus $2.68. Sees…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

UAL

United Continental

$67.99

0.48 (0.71%)

16:24
10/18/17
10/18
16:24
10/18/17
16:24
Hot Stocks
United Continental says Q3 pre-tax income reduced by about $185M due to storms »

During the quarter, the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Oct

BDN

Brandywine Realty

$17.93

-0.02 (-0.11%)

16:24
10/18/17
10/18
16:24
10/18/17
16:24
Earnings
Brandywine Realty sees FY18 EPS of 34c-44c, consensus 25c »

Announces 2018 FFO…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Oct

  • 14

    Dec

CCI

Crown Castle

$101.03

-0.315 (-0.31%)

16:23
10/18/17
10/18
16:23
10/18/17
16:23
Earnings
Crown Castle reports Q3 adjusted EPS 21c, consensus 24c »

Reports Q3 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

TSC

TriState Capital

$22.75

-0.2 (-0.87%)

16:23
10/18/17
10/18
16:23
10/18/17
16:23
Earnings
TriState Capital reports Q3 EPS 35c, consensus 30c »

Reprots Q3 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Oct

  • 06

    Nov

TBK

Triumph Bancorp

$31.80

0.25 (0.79%)

16:23
10/18/17
10/18
16:23
10/18/17
16:23
Earnings
Triumph Bancorp reports Q3 EPS 47C, consensus 44C »

Reports Q3 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Oct

  • 15

    Nov

BDN

Brandywine Realty

$17.93

-0.02 (-0.11%)

16:23
10/18/17
10/18
16:23
10/18/17
16:23
Earnings
Brandywine Realty raises FY17 EPS view to 72c-74c from 17c-21c »

Consensus 24c. Adjusting…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Oct

  • 14

    Dec

HXL

Hexcel

$58.94

0.39 (0.67%)

16:22
10/18/17
10/18
16:22
10/18/17
16:22
Earnings
Hexcel reports Q3 EPS 71c, consensus 68c »

Reports Q3 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

EBAY

eBay

$37.97

0.48 (1.28%)

16:22
10/18/17
10/18
16:22
10/18/17
16:22
Hot Stocks
eBay added 2M active buyers in Q3 »

In the third quarter,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

BPFH

Boston Private Financial

$16.50

0.2 (1.23%)

16:22
10/18/17
10/18
16:22
10/18/17
16:22
Earnings
Boston Private Financial reports Q3 EPS 22c, consensus 23c »

Average total deposits…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Oct

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.